Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial

BACKGROUND: A second antipsychotic is commonly added to clozapine to treat refractory schizophrenia, notwithstanding the limited evidence to support such practice. METHODS: The efficacy and adverse effects of this pharmacological strategy were examined in a double-blind, placebo-controlled, 12-week...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Psychopharmacol
Main Authors: Barnes, Thomas R.E., Leeson, Verity, Paton, Carol, Marston, Louise, Osborn, David P., Kumar, Raj, Keown, Patrick, Zafar, Rameez, Iqbal, Khalid, Singh, Vineet, Fridrich, Pavel, Fitzgerald, Zachary, Bagalkote, Hemant, Haddad, Peter M., Husni, Mariwan, Amos, Tim
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6022882/
https://ncbi.nlm.nih.gov/pubmed/29977519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125318762365
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados